Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study ; volume:5 ; number:1 ; day:24 ; month:8 ; year:2005 ; pages:1-7 ; date:12.2005
BMC infectious diseases ; 5, Heft 1 (24.8.2005), 1-7, 12.2005
- Creator
-
Manosuthi, Weerawat
- Contributor
-
Chumpathat, Nopphanath
Chaovavanich, Achara
Sungkanuparph, Somnuek
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-5-67
- URN
-
urn:nbn:de:1111-2016030246476
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Manosuthi, Weerawat
- Chumpathat, Nopphanath
- Chaovavanich, Achara
- Sungkanuparph, Somnuek
- SpringerLink (Online service)
Other Objects (12)
High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis
Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis
Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole
Fungal Ecology in a Tertiary Neonatal Intensive Care Unit after 16 Years of Routine Fluconazole Prophylaxis: No Emergence of Native Fluconazole-Resistant Strains
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
A Study of Clearance of Infection in HIV-Associated Cryptococcal Meningitis after Amphotericin-Based Induction and Fluconazole-Based Consolidation Therapy
Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients
Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa
Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis
Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta-analysis of randomized controlled trials
Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study
High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis
Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis
Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole
Fungal Ecology in a Tertiary Neonatal Intensive Care Unit after 16 Years of Routine Fluconazole Prophylaxis: No Emergence of Native Fluconazole-Resistant Strains
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
A Study of Clearance of Infection in HIV-Associated Cryptococcal Meningitis after Amphotericin-Based Induction and Fluconazole-Based Consolidation Therapy
Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients
Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa
Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis
Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta-analysis of randomized controlled trials
Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study
High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis
Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis
Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole
Fungal Ecology in a Tertiary Neonatal Intensive Care Unit after 16 Years of Routine Fluconazole Prophylaxis: No Emergence of Native Fluconazole-Resistant Strains
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
A Study of Clearance of Infection in HIV-Associated Cryptococcal Meningitis after Amphotericin-Based Induction and Fluconazole-Based Consolidation Therapy
Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients
Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa
Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis
Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta-analysis of randomized controlled trials